VivoSim Labs VIVS
NASDAQ VIVS
$0.29 +0.01 (+3.06%)
At close: Aug 21, 2026 · 4:00 PM EDT

VivoSim Labs (VIVS) Net Equity Issued and Repurchased (2010 - 2026)

VivoSim Labs (VIVS) posted quarterly Net Equity Issued and Repurchased of $3.0 million for Q1 2026, down 5.9% year-over-year from $3.2 million in Q1 2025, and up 66.5% quarter-over-quarter from $1.8 million in Q4 2025.

VivoSim Labs (VIVS) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

VivoSim Labs' Net Equity Issued and Repurchased history runs 12 years deep, the most recent figure standing at $3.0 million for Q1 2026.

  • In Q1 2026, Net Equity Issued and Repurchased fell 5.9% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $8.4 million (down 8.24% YoY), while the FY2026 annual figure was $4.8 million, down 45.65% from the prior year.
  • Net Equity Issued and Repurchased for Q1 2026 stood at $3.0 million, up from $1.8 million in the prior quarter.
  • The five-year high for Net Equity Issued and Repurchased was $6.2 million in Q2 2024, with the low at -$371000.0 in Q3 2024.
  • The 4-year median for Net Equity Issued and Repurchased is $1.8 million (2025), against an average of $1.9 million.
  • The sharpest annual moves came in 2024 and 2025: Net Equity Issued and Repurchased sank 91.47% in 2024, then surged 1700.0% in 2025.
  • VivoSim Labs' Net Equity Issued and Repurchased stood at $1.2 million in 2023, then tumbled by 91.47% to $100000.0 in 2024, then soared by 1700.0% to $1.8 million in 2025, then surged by 66.5% to $3.0 million in 2026.
  • Business Quant data shows VIVS's Net Equity Issued and Repurchased at $3.0 million in Q1 2026, $1.8 million in Q4 2025, and $1.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 VivoSim Labs 1.49 Mn 1.49 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.00 Mn
Mar 31, 2026 3.00 Mn
Dec 31, 2025 1.80 Mn
Dec 31, 2025 1.80 Mn
Sep 30, 2025 1.80 Mn
Sep 30, 2025 1.80 Mn
Jun 30, 2025 1.81 Mn
Jun 30, 2025 1.81 Mn
Mar 31, 2025 3.19 Mn
Mar 31, 2025 3.19 Mn
Dec 31, 2024 100,000.00
Dec 31, 2024 100,000.00
Sep 30, 2024 -371,000.00
Sep 30, 2024 -371,000.00
Jun 30, 2024 6.25 Mn
Jun 30, 2024 6.25 Mn
Mar 31, 2024 264,000.00
Mar 31, 2024 264,000.00
Dec 31, 2023 1.17 Mn
Dec 31, 2023 1.17 Mn